SCHEMBL22947283

SCHEMBL22947283

c1ccc(-c2nc(-c3ccc4c(c3)[Si](c3ccccc3)(c3ccccc3)c3ccccc3-4)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
ADORA2A P29274 4/20 0.35
ADORA1 P30542 4/20 0.35
GSTP1 P09211 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
HSD17B1 P14061 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869124 0.97 MEN1 (0.40) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL23869233 0.97 MEN1 (0.40) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL23869072 0.95 MEN1 (0.38) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL22949026 0.93 MEN1 (0.39) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL22947367 0.93 MEN1 (0.40) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL22949535 0.92 MEN1 (0.38) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL22947284 0.92 MEN1 (0.41) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL22572812 0.92 MEN1 (0.39) MEN1KMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL22947232 0.91 CTRC (0.41) MEN1KMT2AALDH1A1CYP1A2KDM4E
SCHEMBL23869125 0.90 MEN1 (0.40) MEN1KMT2AALDH1A1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MEN1 2439/4885KMT2A 2115/4885ALDH1A1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.